ETRAVIRINE

ETRAVIRINE was reported 4438 times

ETRAVIRINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA 91 0.7054
1 CHILD-PUGH-TURCOTTE SCORE 2 0.6667
2 ARTERIOVENOUS GRAFT SITE PSEUDOANEURYSM 3 0.6000
3 CLOACAL EXSTROPHY 32 0.5424
4 21-HYDROXYLASE DEFICIENCY 5 0.5000
5 BLADDER AGENESIS 33 0.4459
6 LENTICULAR OPERATION 3 0.3333
7 HYPERANDROGENISM 30 0.3191
8 GASTROINTESTINAL DISORDER CONGENITAL 32 0.3019
9 CONGENITAL ECTOPIC BLADDER 10 0.2083
10 SPASTIC PARAPLEGIA 7 0.2000
11 CAUDAL REGRESSION SYNDROME 31 0.1987
12 ENLARGED CLITORIS 32 0.1939
13 GENITALIA EXTERNAL AMBIGUOUS 31 0.1792
14 MECONIUM STAIN 27 0.1753
15 CONGENITAL GENITAL MALFORMATION 25 0.1562
16 TETHERED CORD SYNDROME 30 0.1357
17 MITOCHONDRIAL TOXICITY 110 0.1340
18 ANORECTAL HUMAN PAPILLOMA VIRUS INFECTION 4 0.1333
19 CONGENITAL MUSCULOSKELETAL DISORDER OF SPINE 6 0.1176
20 MITOCHONDRIAL DNA DEPLETION 4 0.1143
21 GASTROINTESTINAL MALFORMATION 22 0.1053
22 CD4 LYMPHOCYTES ABNORMAL 22 0.1048
23 CONGENITAL MUSCULOSKELETAL DISORDER 9 0.1034
24 ACUTE HAEMORRHAGIC CONJUNCTIVITIS 3 0.1000
25 LIPODYSTROPHY ACQUIRED 175 0.0824
26 CONGENITAL GENITAL MALFORMATION FEMALE 4 0.0816
27 ANTIVIRAL DRUG LEVEL BELOW THERAPEUTIC 3 0.0811
28 VASCULAR STENT RESTENOSIS 7 0.0745
29 ADRENOGENITAL SYNDROME 10 0.0741
30 EXOMPHALOS 38 0.0708
31 UMBILICAL CORD ABNORMALITY 31 0.0588
32 BLOOD HIV RNA 3 0.0577
33 TERTIARY ADRENAL INSUFFICIENCY 3 0.0556
34 CERVIX OPERATION 3 0.0545
35 MENINGOMYELOCELE 32 0.0533
36 CD4 LYMPHOCYTES DECREASED 111 0.0518
37 ANAL ATRESIA 25 0.0468
38 ANOGENITAL DYSPLASIA 7 0.0467
39 MITOCHONDRIAL MYOPATHY ACQUIRED 3 0.0462
40 SPINE MALFORMATION 16 0.0461
41 VIROLOGIC FAILURE 237 0.0440
42 MUSCULOSKELETAL DEFORMITY 10 0.0427
43 VIRAL MUTATION IDENTIFIED 155 0.0420
44 SUBACUTE COMBINED CORD DEGENERATION 7 0.0400
45 ANTIVIRAL DRUG LEVEL ABOVE THERAPEUTIC 3 0.0400
46 CHORIOAMNIONITIS 7 0.0368
47 URINE PHOSPHORUS INCREASED 4 0.0367
48 MONKEYPOX 10 0.0362
49 NEONATAL CHOLESTASIS 3 0.0357
50 EXTRAOCULAR MUSCLE PARESIS 15 0.0327
51 ASSISTED SUICIDE 2 0.0286
52 FIBROUS HISTIOCYTOMA 10 0.0285
53 HYPERPHOSPHATASAEMIA 3 0.0273
54 HIV-ASSOCIATED NEUROCOGNITIVE DISORDER 3 0.0270
55 BONE DEMINERALISATION 28 0.0264
56 CONGENITAL MUSCULOSKELETAL ANOMALY 11 0.0249
57 NEONATAL HYPONATRAEMIA 3 0.0246
58 CHOROIDITIS 9 0.0241
59 AMYLASE ABNORMAL 3 0.0240
60 CHILD-PUGH-TURCOTTE SCORE INCREASED 2 0.0235
61 ADRENAL SUPPRESSION 19 0.0225
62 DRUG WITHDRAWAL MAINTENANCE THERAPY 3 0.0213
63 OPHTHALMOPLEGIA 33 0.0209
64 ANAPHYLACTOID SYNDROME OF PREGNANCY 2 0.0208
65 ANENCEPHALY 11 0.0195
66 CALCULUS URETHRAL 3 0.0194
67 NEURAL TUBE DEFECT 14 0.0193
68 HIV VIRAEMIA 4 0.0190
69 ANAEMIA NEONATAL 9 0.0187
70 NEPHROANGIOSCLEROSIS 3 0.0186
71 IMMUNE RECONSTITUTION SYNDROME 23 0.0178
72 BLOOD CREATINE PHOSPHOKINASE ABNORMAL 8 0.0177
73 CHRONIC HEPATITIS C 7 0.0177
74 FAT REDISTRIBUTION 4 0.0172
75 HYPOURICAEMIA 5 0.0172
76 ACUTE HEPATITIS C 3 0.0164
77 ACANTHOSIS NIGRICANS 3 0.0162
78 INSULIN-REQUIRING TYPE 2 DIABETES MELLITUS 5 0.0162
79 SEPSIS NEONATAL 13 0.0160
80 ANASTOMOTIC HAEMORRHAGE 3 0.0158
81 PATHOGEN RESISTANCE 139 0.0152
82 CHOLESTASIS OF PREGNANCY 7 0.0152
83 MYCOBACTERIUM TEST POSITIVE 3 0.0146
84 ATYPICAL MYCOBACTERIAL PNEUMONIA 2 0.0144
85 RENAL TUBULAR DYSFUNCTION 8 0.0142
86 TRICHOPHYTOSIS 3 0.0142
87 CEREBRAL HAEMORRHAGE NEONATAL 3 0.0142
88 BETA 2 MICROGLOBULIN URINE INCREASED 2 0.0140
89 SUPERINFECTION BACTERIAL 11 0.0139
90 MULTIPLE-DRUG RESISTANCE 43 0.0139
91 ACQUIRED IMMUNODEFICIENCY SYNDROME 7 0.0135
92 PERINEAL ABSCESS 6 0.0133
93 BLOOD HIV RNA INCREASED 24 0.0132
94 CHRONIC TONSILLITIS 2 0.0131
95 LIPOHYPERTROPHY 8 0.0129
96 CYTOMEGALOVIRUS CHORIORETINITIS 25 0.0128
97 GENOTYPE DRUG RESISTANCE TEST POSITIVE 13 0.0126
98 MACULAR DETACHMENT 3 0.0124
99 HEART TRANSPLANT REJECTION 12 0.0116
100 HELLP SYNDROME 7 0.0114
101 SKIN BACTERIAL INFECTION 9 0.0112
102 ANTITHROMBIN III DECREASED 3 0.0110
103 VIRAEMIA 15 0.0108
104 FANCONI SYNDROME ACQUIRED 19 0.0108
105 GASTROINTESTINAL MUCOSAL DISORDER 7 0.0107
106 PNEUMOCOCCAL SEPSIS 7 0.0107
107 HAEMORRHAGIC ASCITES 3 0.0105
108 EYELID PTOSIS 107 0.0105
109 TRICHODYSPLASIA SPINULOSA 4 0.0105
110 ERYTHEMA ANNULARE 3 0.0103
111 DRUG RESISTANCE 266 0.0103
112 CD8 LYMPHOCYTES DECREASED 2 0.0100
113 ANAL CANCER 9 0.0093
114 HIV INFECTION 27 0.0089
115 VIRAL LOAD INCREASED 34 0.0087
116 MYCOBACTERIAL INFECTION 15 0.0087
117 BRAIN MALFORMATION 3 0.0084
118 HYPOTHALAMIC PITUITARY ADRENAL AXIS SUPPRESSION 3 0.0084
119 ANHEDONIA 219 0.0083
120 PSEUDOMONAL BACTERAEMIA 7 0.0082
121 RENAL TUBULAR DISORDER 23 0.0082
122 PRODUCT DIFFICULT TO SWALLOW 8 0.0079
123 BLOOD MAGNESIUM INCREASED 7 0.0078
124 PLACENTA PRAEVIA 6 0.0076
125 HAEMOCHROMATOSIS 7 0.0076
126 OPPORTUNISTIC INFECTION 14 0.0076
127 HEPATITIS B DNA INCREASED 5 0.0074
128 AMNIOTIC FLUID VOLUME DECREASED 4 0.0073
129 GRANULOMATOUS LIVER DISEASE 5 0.0071
130 OSTEOCHONDROSIS 8 0.0069
131 SYPHILIS 5 0.0069
132 PRODUCT COATING ISSUE 7 0.0069
133 MITOCHONDRIAL CYTOPATHY 3 0.0068
134 SPINA BIFIDA 14 0.0067
135 POSTPARTUM HAEMORRHAGE 9 0.0067
136 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 33 0.0066
137 BONE INFARCTION 3 0.0066
138 ANAL SQUAMOUS CELL CARCINOMA 2 0.0065
139 FANCONI SYNDROME 9 0.0064
140 MYCOBACTERIUM AVIUM COMPLEX INFECTION 17 0.0063
141 ANTICOAGULATION DRUG LEVEL INCREASED 2 0.0062
142 PREMATURE LABOUR 35 0.0062
143 INTRAOCULAR LENS IMPLANT 3 0.0061
144 FOREIGN BODY 24 0.0060
145 ASPARTATE AMINOTRANSFERASE ABNORMAL 9 0.0059
146 MYCOTIC ALLERGY 5 0.0058
147 CUSHING'S SYNDROME 4 0.0058
148 CIRCUMORAL OEDEMA 2 0.0057
149 GENE MUTATION 11 0.0056
150 CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY 6 0.0055
151 ECONOMIC PROBLEM 84 0.0055
152 OESOPHAGEAL CANDIDIASIS 22 0.0055
153 OSTEOPENIA 82 0.0054
154 VANISHING BILE DUCT SYNDROME 6 0.0054
155 LIPOATROPHY 5 0.0053
156 CARDIORENAL SYNDROME 3 0.0052
157 AMYOTROPHY 2 0.0052
158 GLYCOSURIA 7 0.0052
159 CEREBRAL ARTERIOSCLEROSIS 2 0.0052
160 RETROPERITONEAL FIBROSIS 3 0.0051
161 VITRECTOMY 3 0.0050
162 HEPATORENAL FAILURE 3 0.0050
163 DYSLIPIDAEMIA 25 0.0049
164 RENAL COLIC 11 0.0049
165 MYOPATHY TOXIC 3 0.0049
166 ALVEOLITIS ALLERGIC 5 0.0048
167 HEPATORENAL SYNDROME 8 0.0047
168 ARTERIAL DISORDER 9 0.0047
169 PREMATURE RUPTURE OF MEMBRANES 11 0.0046
170 PREMATURE SEPARATION OF PLACENTA 7 0.0045
171 OSTEOMALACIA 7 0.0045
172 NEONATAL RESPIRATORY DISTRESS SYNDROME 16 0.0045
173 PNEUMOCYSTIS JIROVECI PNEUMONIA 10 0.0045
174 SUBSTANCE USE 7 0.0045
175 PRECANCEROUS CONDITION 3 0.0045
176 BLOOD LACTIC ACID INCREASED 23 0.0044
177 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 14 0.0043
178 LOW BIRTH WEIGHT BABY 34 0.0043
179 ALANINE AMINOTRANSFERASE ABNORMAL 9 0.0043
180 METABOLIC SYNDROME 7 0.0043
181 SPINAL CORD DISORDER 7 0.0043
182 INTUSSUSCEPTION 4 0.0042
183 PYELOCALIECTASIS 4 0.0042
184 LIPIDS ABNORMAL 3 0.0041
185 GENERALISED ANXIETY DISORDER 6 0.0041
186 ABORTION THREATENED 2 0.0040
187 NEGATIVISM 3 0.0040
188 DIPLOPIA 101 0.0039
189 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 4 0.0038
190 HYPERPARATHYROIDISM SECONDARY 9 0.0036
191 UNDERWEIGHT 7 0.0035
192 GLOMERULAR FILTRATION RATE ABNORMAL 5 0.0035
193 FAT TISSUE INCREASED 5 0.0034
194 HYPERLEUKOCYTOSIS 3 0.0034
195 HEPATITIS B 20 0.0033
196 CYTOLYTIC HEPATITIS 11 0.0033
197 CEREBELLAR ATAXIA 3 0.0031
198 BLOOD CORTISOL DECREASED 2 0.0031
199 OSTEOPOROSIS 127 0.0031
200 OROPHARYNGEAL SWELLING 3 0.0030
201 HYPOVITAMINOSIS 4 0.0030
202 PROTEIN TOTAL INCREASED 8 0.0030
203 NEPHROPATHY 28 0.0030
204 HYPOCHROMIC ANAEMIA 3 0.0030
205 FIBROSIS 9 0.0029
206 PORTAL HYPERTENSION 9 0.0029
207 PREMATURE BABY 87 0.0029
208 CARDIOVERSION 4 0.0029
209 PERIODONTAL DISEASE 4 0.0029
210 END STAGE RENAL DISEASE 52 0.0028
211 CONGENITAL ANOMALY 22 0.0028
212 SMALL FOR DATES BABY 14 0.0028
213 AMNIOTIC CAVITY INFECTION 2 0.0028
214 TINEA INFECTION 3 0.0027
215 BONE DENSITY DECREASED 85 0.0027
216 PNEUMONIA PNEUMOCOCCAL 4 0.0027
217 HEPATITIS TOXIC 7 0.0027
218 LICHENOID KERATOSIS 6 0.0026
219 BLOOD IRON DECREASED 31 0.0026
220 DRUG LEVEL INCREASED 43 0.0026
221 POLYDACTYLY 3 0.0026
222 CHRONIC ALLOGRAFT NEPHROPATHY 2 0.0026
223 CHRONIC KIDNEY DISEASE 192 0.0025
224 INTRA-UTERINE DEATH 4 0.0025
225 LIPIDS INCREASED 5 0.0025
226 BLOOD PHOSPHORUS DECREASED 9 0.0025
227 TREATMENT FAILURE 203 0.0024
228 HYPERPARATHYROIDISM 5 0.0024
229 HEPATITIS C 29 0.0024
230 AORTIC VALVE REPLACEMENT 3 0.0024
231 GLUCOSE TOLERANCE IMPAIRED 14 0.0024
232 ADENOCARCINOMA PANCREAS 3 0.0023
233 PRE-ECLAMPSIA 11 0.0023
234 GESTATIONAL DIABETES 11 0.0023
235 MALABSORPTION 12 0.0023
236 RENAL TUBULAR ACIDOSIS 5 0.0023
237 MULTIPLE FRACTURES 37 0.0022
238 CYTOMEGALOVIRUS TEST POSITIVE 4 0.0022
239 ANOGENITAL WARTS 2 0.0022
240 CARDIAC ABLATION 4 0.0022
241 PRODUCT SIZE ISSUE 12 0.0022
242 HYPERTRIGLYCERIDAEMIA 13 0.0022
243 CERUMEN IMPACTION 2 0.0022
244 PRODUCT SOLUBILITY ABNORMAL 11 0.0022
245 VITREOUS HAEMORRHAGE 6 0.0022
246 RASH MORBILLIFORM 6 0.0022
247 LOBAR PNEUMONIA 4 0.0022
248 DEATH NEONATAL 3 0.0022
249 HEPATITIS ACUTE 14 0.0022
250 CEREBRAL TOXOPLASMOSIS 2 0.0021
251 PRERENAL FAILURE 3 0.0021
252 RADIUS FRACTURE 5 0.0021
253 STAPHYLOCOCCAL BACTERAEMIA 9 0.0021
254 FOETAL EXPOSURE DURING PREGNANCY 166 0.0020
255 PYELONEPHRITIS ACUTE 4 0.0020
256 DECREASED ACTIVITY 22 0.0020
257 GROWTH RETARDATION 6 0.0020
258 PROSTATOMEGALY 8 0.0020
259 LIVE BIRTH 17 0.0020
260 LYMPHOEDEMA 14 0.0020
261 EMOTIONAL DISTRESS 243 0.0020
262 DEPRESSIVE SYMPTOM 7 0.0020
263 HYPERCHOLESTEROLAEMIA 19 0.0020
264 DRUG LEVEL DECREASED 20 0.0020
265 GENITAL HERPES 3 0.0020
266 HYPERURICAEMIA 8 0.0019
267 CACHEXIA 10 0.0019
268 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 16 0.0019
269 BENIGN PROSTATIC HYPERPLASIA 10 0.0019
270 EPSTEIN-BARR VIRUS INFECTION 12 0.0019
271 IDIOPATHIC THROMBOCYTOPENIC PURPURA 3 0.0019
272 CHOLESTASIS 36 0.0019
273 NEPHROPATHY TOXIC 21 0.0019
274 STILLBIRTH 9 0.0019
275 HYPOGLYCAEMIA NEONATAL 3 0.0019
276 CYTOMEGALOVIRUS VIRAEMIA 8 0.0018
277 BONE LOSS 27 0.0018
278 PROTEINURIA 34 0.0018
279 KLEBSIELLA INFECTION 9 0.0018
280 DRUG INTERACTION 282 0.0018
281 TREATMENT NONCOMPLIANCE 97 0.0018
282 BILIARY DYSKINESIA 3 0.0018
283 HYPOPHOSPHATAEMIA 13 0.0018
284 PREMATURE DELIVERY 28 0.0018
285 HEPATIC CIRRHOSIS 33 0.0018
286 EXPOSURE DURING PREGNANCY 109 0.0018
287 BLOOD CREATININE ABNORMAL 6 0.0017
288 VITAMIN B12 DEFICIENCY 7 0.0017
289 HEPATIC STEATOSIS 32 0.0017
290 MENINGITIS CRYPTOCOCCAL 3 0.0017
291 GLOMERULAR FILTRATION RATE DECREASED 21 0.0017
292 BONE MARROW TOXICITY 2 0.0017
293 HAEMORRHAGIC DIATHESIS 6 0.0017
294 OSTEONECROSIS 55 0.0017
295 DERMATITIS ALLERGIC 21 0.0017
296 VARICES OESOPHAGEAL 5 0.0017
297 QUALITY OF LIFE DECREASED 22 0.0016
298 HEPATIC ENCEPHALOPATHY 15 0.0016
299 GASTROINTESTINAL TUBE INSERTION 4 0.0016
300 HYPERLIPIDAEMIA 19 0.0016
301 NARCOLEPSY 3 0.0016
302 TOXIC SKIN ERUPTION 16 0.0016
303 LIP DISORDER 3 0.0016
304 ABORTION MISSED 2 0.0016
305 HEPATITIS B REACTIVATION 5 0.0016
306 CUSHINGOID 5 0.0016
307 HYPERBILIRUBINAEMIA 16 0.0015
308 FOETAL DEATH 8 0.0015
309 ABORTION SPONTANEOUS 61 0.0015
310 VOCAL CORD DISORDER 3 0.0015
311 PNEUMONIA STAPHYLOCOCCAL 3 0.0015
312 NEPHROGENIC ANAEMIA 7 0.0015
313 HEPATITIS CHOLESTATIC 9 0.0015
314 HYPERLACTACIDAEMIA 4 0.0015
315 RENAL MASS 3 0.0015
316 BILIARY TRACT DISORDER 2 0.0014
317 TOOTH LOSS 29 0.0014
318 CORONARY ARTERY BYPASS 8 0.0014
319 POOR QUALITY DRUG ADMINISTERED 9 0.0014
320 MYOPATHY 12 0.0014
321 PHLEBITIS 7 0.0014
322 ORAL DISORDER 10 0.0014
323 PRODUCT FORMULATION ISSUE 9 0.0014
324 FAILURE TO THRIVE 7 0.0013
325 VITAMIN D DEFICIENCY 13 0.0013
326 SPINAL COMPRESSION FRACTURE 11 0.0013
327 HEPATOMEGALY 13 0.0013
328 BLOOD CREATINE PHOSPHOKINASE INCREASED 38 0.0013
329 NYSTAGMUS 7 0.0013
330 HEPATOCELLULAR CARCINOMA 10 0.0013
331 MATERNAL DRUGS AFFECTING FOETUS 10 0.0013
332 HAEMOLYTIC URAEMIC SYNDROME 3 0.0013
333 CHEILITIS 7 0.0013
334 FOOT FRACTURE 24 0.0013
335 NEUROTOXICITY 22 0.0013
336 HEPATITIS 32 0.0012
337 RENAL FAILURE 165 0.0012
338 BLOOD CREATININE INCREASED 81 0.0012
339 PANCYTOPENIA 69 0.0012
340 ANGINA UNSTABLE 8 0.0012
341 SHOCK HAEMORRHAGIC 10 0.0012
342 BACTERIAL SEPSIS 4 0.0012
343 RENAL TUBULAR NECROSIS 12 0.0012
344 ACUTE PSYCHOSIS 3 0.0012
345 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 4 0.0012
346 CARDIAC FAILURE ACUTE 8 0.0012
347 OLIGOHYDRAMNIOS 4 0.0012
348 HEPATOCELLULAR INJURY 17 0.0012
349 CORONARY ARTERY STENOSIS 6 0.0012
350 ACIDOSIS 9 0.0012
351 BRONCHOPNEUMONIA 4 0.0012
352 HEPATIC FIBROSIS 4 0.0012
353 LEFT VENTRICULAR FAILURE 4 0.0012
354 CERVICAL SPINAL STENOSIS 2 0.0012
355 OCULAR ICTERUS 5 0.0012
356 AUTOIMMUNE HEPATITIS 8 0.0011
357 CARPAL TUNNEL SYNDROME 16 0.0011
358 FOOD CRAVING 6 0.0011
359 EXFOLIATIVE RASH 3 0.0011
360 RENAL FAILURE ACUTE 48 0.0011
361 HAND FRACTURE 8 0.0011
362 CHOKING 22 0.0011
363 STEVENS-JOHNSON SYNDROME 25 0.0011
364 RASH MACULO-PAPULAR 25 0.0011
365 DRUG DISPENSING ERROR 17 0.0011
366 SPLENOMEGALY 13 0.0011
367 LIP BLISTER 3 0.0011
368 MATERNAL EXPOSURE DURING PREGNANCY 98 0.0011
369 BLOOD PHOSPHORUS INCREASED 3 0.0011
370 AMYLASE INCREASED 4 0.0011
371 RENAL IMPAIRMENT 91 0.0011
372 HYDRONEPHROSIS 8 0.0011
373 PSYCHOMOTOR RETARDATION 3 0.0011
374 ANTIPSYCHOTIC DRUG LEVEL INCREASED 3 0.0011
375 SKELETAL INJURY 11 0.0011
376 ABORTION INDUCED 10 0.0011
377 IMMUNE THROMBOCYTOPENIC PURPURA 3 0.0011
378 DRUG EXPOSURE DURING PREGNANCY 36 0.0011
379 AUTOIMMUNE THYROIDITIS 4 0.0011
380 SKIN LESION 29 0.0011
381 PSEUDOMONAS INFECTION 9 0.0010
382 VASCULAR GRAFT 3 0.0010
383 MUSCLE STRAIN 9 0.0010
384 RENAL PAIN 11 0.0010
385 HEPATOTOXICITY 23 0.0010
386 PANCREATITIS ACUTE 23 0.0010
387 DRUG-INDUCED LIVER INJURY 32 0.0010
388 POLYDIPSIA 4 0.0010
389 PROTEIN URINE PRESENT 5 0.0010
390 MUSCLE HAEMORRHAGE 4 0.0010
391 TRANSAMINASES INCREASED 22 0.0010
392 MUSCULOSKELETAL DISCOMFORT 17 0.0010
393 MULTI-ORGAN FAILURE 17 0.0010
394 WEIGHT LOSS POOR 5 0.0010
395 ACUTE CORONARY SYNDROME 8 0.0010
396 INVESTIGATION 3 0.0010
397 HEPATIC CYTOLYSIS 12 0.0009
398 IMMUNODEFICIENCY 14 0.0009
399 POLYNEUROPATHY 11 0.0009
400 WRIST FRACTURE 11 0.0009
401 ADRENAL INSUFFICIENCY 11 0.0009
402 BLOOD TRIGLYCERIDES INCREASED 16 0.0009
403 MENINGITIS 6 0.0009
404 ANXIETY DISORDER 3 0.0009
405 PNEUMOCYSTIS JIROVECII PNEUMONIA 9 0.0009
406 HEPATIC FAILURE 27 0.0009
407 ADENOCARCINOMA 2 0.0009
408 APLASIA PURE RED CELL 3 0.0009
409 ISCHAEMIA 4 0.0009
410 EXERCISE TOLERANCE DECREASED 5 0.0009
411 ANXIETY 247 0.0009
412 APHTHOUS STOMATITIS 2 0.0009
413 TACHYPHRENIA 3 0.0009
414 INTERVERTEBRAL DISC DEGENERATION 8 0.0009
415 EOSINOPHILIA 15 0.0009
416 BILIRUBIN CONJUGATED INCREASED 2 0.0009
417 PERIPHERAL SENSORY NEUROPATHY 5 0.0009
418 ANAEMIA 163 0.0009
419 HYPOVOLAEMIA 5 0.0009
420 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 41 0.0009
421 ACUTE RESPIRATORY DISTRESS SYNDROME 15 0.0008
422 LYMPHADENOPATHY 30 0.0008
423 PRODUCT PHYSICAL ISSUE 17 0.0008
424 HAEMATOTOXICITY 8 0.0008
425 CONJUNCTIVAL HYPERAEMIA 3 0.0008
426 ACUTE KIDNEY INJURY 128 0.0008
427 FACIAL BONES FRACTURE 3 0.0008
428 FOETAL GROWTH RESTRICTION 5 0.0008
429 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 21 0.0008
430 RHABDOMYOLYSIS 34 0.0008
431 ENCEPHALOPATHY 20 0.0008
432 PSYCHIATRIC SYMPTOM 6 0.0008
433 PANCREATIC DISORDER 4 0.0008
434 NEURODERMATITIS 3 0.0008
435 LIVER DISORDER 35 0.0008
436 CONJUNCTIVAL HAEMORRHAGE 3 0.0008
437 CLAVICLE FRACTURE 3 0.0008
438 ASPARTATE AMINOTRANSFERASE INCREASED 41 0.0008
439 FACE OEDEMA 13 0.0008
440 SKIN ODOUR ABNORMAL 3 0.0008
441 OESOPHAGEAL PAIN 3 0.0008
442 POLYARTHRITIS 4 0.0008
443 BACTERAEMIA 9 0.0008
444 AGRANULOCYTOSIS 14 0.0008
445 CEREBRAL ATROPHY 3 0.0008
446 HYPERPHAGIA 3 0.0008
447 AZOTAEMIA 3 0.0008
448 TUBULOINTERSTITIAL NEPHRITIS 14 0.0007
449 TRIGEMINAL NEURALGIA 3 0.0007
450 ACUTE MYOCARDIAL INFARCTION 22 0.0007
451 ARTERIOSCLEROSIS 7 0.0007
452 SQUAMOUS CELL CARCINOMA 7 0.0007
453 NERVOUS SYSTEM DISORDER 23 0.0007
454 POLYURIA 6 0.0007
455 DIABETES MELLITUS 55 0.0007
456 CONGESTIVE CARDIOMYOPATHY 3 0.0007
457 HIP ARTHROPLASTY 11 0.0007
458 ASCITES 21 0.0007
459 ANAL HAEMORRHAGE 2 0.0007
460 RENAL INJURY 21 0.0007
461 JAUNDICE 19 0.0007
462 BLOOD BILIRUBIN INCREASED 19 0.0007
463 LEFT VENTRICULAR HYPERTROPHY 3 0.0007
464 SKIN HYPERPIGMENTATION 6 0.0007
465 TEARFULNESS 3 0.0007
466 PARANOIA 12 0.0007
467 PYELONEPHRITIS 6 0.0007
468 AUTONOMIC NERVOUS SYSTEM IMBALANCE 2 0.0007
469 GASTRIC ULCER 13 0.0007
470 RHINITIS ALLERGIC 3 0.0007
471 ODYNOPHAGIA 4 0.0007
472 HAEMARTHROSIS 6 0.0007
473 ALANINE AMINOTRANSFERASE INCREASED 41 0.0007
474 SQUAMOUS CELL CARCINOMA OF SKIN 4 0.0007
475 URINE ABNORMALITY 3 0.0007
476 ATRIOVENTRICULAR BLOCK SECOND DEGREE 2 0.0007
477 ANKLE FRACTURE 10 0.0006
478 CHOLANGITIS 4 0.0006
479 NEUROPATHY PERIPHERAL 61 0.0006
480 TIBIA FRACTURE 3 0.0006
481 TORSADE DE POINTES 5 0.0006
482 TOOTH FRACTURE 7 0.0006
483 WRONG TECHNIQUE IN DRUG USAGE PROCESS 23 0.0006
484 RIB FRACTURE 13 0.0006
485 PRODUCT PACKAGING ISSUE 6 0.0006
486 LOWER LIMB FRACTURE 12 0.0006
487 GASTROINTESTINAL TOXICITY 3 0.0006
488 HUMERUS FRACTURE 3 0.0006
489 HEPATIC ENZYME INCREASED 42 0.0006
490 MYOCARDITIS 7 0.0006
491 LABORATORY TEST ABNORMAL 18 0.0006
492 ASPERGILLUS INFECTION 4 0.0006
493 HICCUPS 5 0.0006
494 INCORRECT PRODUCT STORAGE 8 0.0006
495 GENERALISED TONIC-CLONIC SEIZURE 10 0.0006
496 HYPERNATRAEMIA 3 0.0006
497 HYPERKALAEMIA 21 0.0006
498 ERYSIPELAS 3 0.0006
499 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 3 0.0006
500 B-CELL LYMPHOMA 2 0.0006
501 ACUTE HEPATIC FAILURE 8 0.0006
502 ENDOCARDITIS 3 0.0006
503 DEPRESSION 133 0.0006
504 DYSSTASIA 17 0.0006
505 ENCEPHALITIS 4 0.0006
506 FORMICATION 4 0.0006
507 DYSURIA 21 0.0006
508 JOINT DISLOCATION 6 0.0006
509 NEPHROLITHIASIS 26 0.0006
510 DRUG ERUPTION 10 0.0006
511 GASTROINTESTINAL MOTILITY DISORDER 3 0.0006
512 LEUKOPENIA 28 0.0006
513 MYOSITIS 5 0.0006
514 STRESS FRACTURE 3 0.0006
515 BONE LESION 2 0.0006
516 MYELODYSPLASTIC SYNDROME 8 0.0006
517 BIPOLAR DISORDER 6 0.0006
518 SEPTIC SHOCK 24 0.0006
519 LIVER FUNCTION TEST ABNORMAL 16 0.0005
520 PANCREATITIS 29 0.0005
521 VENTRICULAR TACHYCARDIA 9 0.0005
522 INTESTINAL ISCHAEMIA 3 0.0005
523 CHOKING SENSATION 3 0.0005
524 ALCOHOL USE 2 0.0005
525 RASH GENERALISED 14 0.0005
526 HIATUS HERNIA 7 0.0005
527 THROMBOCYTOPENIA 60 0.0005
528 BONE DENSITY ABNORMAL 2 0.0005
529 ORAL CANDIDIASIS 7 0.0005
530 STATUS EPILEPTICUS 6 0.0005
531 AGITATION 39 0.0005
532 SKIN TOXICITY 3 0.0005
533 CEREBRAL HAEMORRHAGE 19 0.0005
534 VENTRICULAR SEPTAL DEFECT 3 0.0005
535 RENAL FAILURE CHRONIC 4 0.0005
536 PRESCRIBED OVERDOSE 10 0.0005
537 RENAL DISORDER 24 0.0005
538 ERECTILE DYSFUNCTION 13 0.0005
539 TYPE 2 DIABETES MELLITUS 17 0.0005
540 RENAL CYST 4 0.0005
541 ACCIDENT 6 0.0005
542 TRANSPLANT REJECTION 4 0.0005
543 BLOOD DISORDER 4 0.0005
544 TYPE 1 DIABETES MELLITUS 3 0.0005
545 BONE DISORDER 9 0.0005
546 BLOOD CHOLESTEROL INCREASED 23 0.0005
547 INGUINAL HERNIA 3 0.0005
548 NO THERAPEUTIC RESPONSE 6 0.0005
549 TOOTH ABSCESS 5 0.0005
550 DYSPHAGIA 46 0.0005
551 PULMONARY ARTERIAL HYPERTENSION 7 0.0005
552 ATRIAL SEPTAL DEFECT 4 0.0005
553 PHOTOPSIA 3 0.0005
554 GASTROINTESTINAL DISORDER 42 0.0005
555 DRUG PRESCRIBING ERROR 9 0.0005
556 PAIN 286 0.0005
557 ANOREXIA 6 0.0005
558 SKIN ULCER 12 0.0005
559 TENDON DISORDER 3 0.0005
560 GAIT DISTURBANCE 88 0.0005
561 SOMNAMBULISM 3 0.0005
562 POLLAKIURIA 19 0.0005
563 SPINAL OSTEOARTHRITIS 4 0.0005
564 ANGINA PECTORIS 13 0.0005
565 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 4 0.0005
566 GAMMA-GLUTAMYLTRANSFERASE INCREASED 10 0.0005
567 CEREBRAL INFARCTION 11 0.0004
568 OBSTRUCTIVE AIRWAYS DISORDER 5 0.0004
569 LEFT VENTRICULAR DYSFUNCTION 3 0.0004
570 HAEMOLYTIC ANAEMIA 4 0.0004
571 BRONCHIECTASIS 3 0.0004
572 POSTOPERATIVE WOUND INFECTION 3 0.0004
573 HYPONATRAEMIA 25 0.0004
574 MITRAL VALVE INCOMPETENCE 5 0.0004
575 OPTIC NEURITIS 4 0.0004
576 BLOOD TESTOSTERONE DECREASED 3 0.0004
577 CORONARY ARTERY OCCLUSION 6 0.0004
578 HAIR GROWTH ABNORMAL 3 0.0004
579 HYPERTRANSAMINASAEMIA 3 0.0004
580 CAESAREAN SECTION 5 0.0004
581 BLOOD PROLACTIN INCREASED 2 0.0004
582 FRACTURE 8 0.0004
583 CHRONIC LYMPHOCYTIC LEUKAEMIA 2 0.0004
584 GLAUCOMA 8 0.0004
585 TONGUE DISORDER 3 0.0004
586 HYPERTHYROIDISM 6 0.0004
587 NOCTURIA 5 0.0004
588 APATHY 6 0.0004
589 AUTOIMMUNE DISORDER 4 0.0004
590 CARDIOMYOPATHY 6 0.0004
591 LOWER GASTROINTESTINAL HAEMORRHAGE 3 0.0004
592 GENERALISED OEDEMA 5 0.0004
593 ORTHOSTATIC HYPOTENSION 7 0.0004
594 POISONING 5 0.0004
595 HYPOTHERMIA 4 0.0004
596 TOXIC EPIDERMAL NECROLYSIS 6 0.0004
597 LIPASE INCREASED 3 0.0004
598 DIFFUSE LARGE B-CELL LYMPHOMA 3 0.0004
599 HYPERTENSION 82 0.0004
600 HYPERGLYCAEMIA 14 0.0004
601 APLASTIC ANAEMIA 2 0.0004
602 PRODUCT USE COMPLAINT 6 0.0004
603 PYREXIA 131 0.0004
604 MYOCARDIAL INFARCTION 66 0.0004
605 BLOOD ALBUMIN DECREASED 3 0.0004
606 SUDDEN DEATH 4 0.0004
607 RETCHING 8 0.0004
608 HEPATIC FUNCTION ABNORMAL 14 0.0004
609 NEOPLASM PROGRESSION 13 0.0004
610 DYSARTHRIA 14 0.0004
611 PRURITUS GENERALISED 8 0.0004
612 BLOOD URINE PRESENT 7 0.0004
613 LIVER INJURY 9 0.0004
614 ESCHERICHIA INFECTION 3 0.0004
615 BLOOD ALKALINE PHOSPHATASE INCREASED 9 0.0004
616 MOBILITY DECREASED 26 0.0004
617 EOSINOPHIL COUNT INCREASED 3 0.0004
618 MALNUTRITION 4 0.0004
619 HAEMODIALYSIS 3 0.0004
620 RESTLESSNESS 13 0.0004
621 HAEMATEMESIS 9 0.0004
622 DIALYSIS 5 0.0004
623 UPPER LIMB FRACTURE 7 0.0004
624 CARDIAC VALVE DISEASE 2 0.0003
625 LUNG INFILTRATION 3 0.0003
626 NEUTROPENIA 46 0.0003
627 ATAXIA 4 0.0003
628 DRUG INTOLERANCE 32 0.0003
629 IMPAIRED WORK ABILITY 7 0.0003
630 UROSEPSIS 3 0.0003
631 HYPERCALCAEMIA 4 0.0003
632 LYMPHOMA 5 0.0003
633 OSTEONECROSIS OF JAW 8 0.0003
634 PHARYNGITIS 4 0.0003
635 MENTAL DISORDER 14 0.0003
636 HAEMATURIA 11 0.0003
637 INTERVERTEBRAL DISC PROTRUSION 7 0.0003
638 FLANK PAIN 3 0.0003
639 NIGHTMARE 11 0.0003
640 SPINAL DISORDER 3 0.0003
641 ADVERSE EVENT 29 0.0003
642 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 3 0.0003
643 OBESITY 5 0.0003
644 SEPSIS 35 0.0003
645 VERTIGO 19 0.0003
646 OSTEOARTHRITIS 13 0.0003
647 NERVOUSNESS 16 0.0003
648 HYPOKALAEMIA 14 0.0003
649 ARTERIOSCLEROSIS CORONARY ARTERY 2 0.0003
650 RASH 131 0.0003
651 SPINAL FRACTURE 6 0.0003
652 JOINT RANGE OF MOTION DECREASED 4 0.0003
653 CORONARY ARTERY DISEASE 9 0.0003
654 THERAPEUTIC RESPONSE DECREASED 18 0.0003
655 BONE MARROW FAILURE 6 0.0003
656 UVEITIS 4 0.0003
657 TACHYCARDIA 26 0.0003
658 RESPIRATORY DISTRESS 8 0.0003
659 ABNORMAL DREAMS 8 0.0003
660 HYPOGLYCAEMIA 14 0.0003
661 TENDERNESS 3 0.0003
662 PROSTATE CANCER 23 0.0003
663 GENERAL PHYSICAL HEALTH DETERIORATION 33 0.0003
664 DISSEMINATED INTRAVASCULAR COAGULATION 4 0.0003
665 INTERNATIONAL NORMALISED RATIO INCREASED 8 0.0003
666 HIP FRACTURE 9 0.0003
667 LACTIC ACIDOSIS 9 0.0003
668 AMNESIA 18 0.0003
669 ASTHENIA 104 0.0003
670 ANOSMIA 4 0.0003
671 GASTROENTERITIS 4 0.0003
672 ASPIRATION 3 0.0003
673 ANGIOEDEMA 12 0.0003
674 BLINDNESS TRANSIENT 2 0.0003
675 VISUAL ACUITY REDUCED 9 0.0003
676 HYPERTENSIVE CRISIS 3 0.0003
677 CONJUNCTIVITIS 5 0.0003
678 MUCOSAL INFLAMMATION 7 0.0003
679 INTESTINAL PERFORATION 3 0.0003
680 HYPOAESTHESIA 40 0.0003
681 TOXICITY TO VARIOUS AGENTS 45 0.0003
682 LOWER RESPIRATORY TRACT INFECTION 12 0.0003
683 MYOCARDIAL ISCHAEMIA 3 0.0003
684 MICTURITION URGENCY 3 0.0003
685 DEHYDRATION 35 0.0003
686 TINNITUS 12 0.0003
687 DRUG ADMINISTRATION ERROR 8 0.0003
688 CONFUSIONAL STATE 42 0.0003
689 DEVICE RELATED INFECTION 4 0.0003
690 BRONCHOPULMONARY ASPERGILLOSIS 2 0.0003
691 LUNG INFECTION 4 0.0003
692 SEXUAL DYSFUNCTION 3 0.0003
693 SLEEP DISORDER 18 0.0003
694 AFFECTIVE DISORDER 2 0.0003
695 ABDOMINAL PAIN 59 0.0003
696 CHOLECYSTITIS 3 0.0003
697 MUSCLE RIGIDITY 3 0.0003
698 BLOOD POTASSIUM INCREASED 4 0.0002
699 ABNORMAL FAECES 2 0.0002
700 SMALL INTESTINAL OBSTRUCTION 3 0.0002
701 ERYTHEMA 50 0.0002
702 PANCREATIC CARCINOMA 7 0.0002
703 PULMONARY EMBOLISM 23 0.0002
704 DEATH 208 0.0002
705 COAGULOPATHY 4 0.0002
706 PULMONARY HYPERTENSION 5 0.0002
707 OEDEMA 13 0.0002
708 CARDIO-RESPIRATORY ARREST 10 0.0002
709 BLOOD UREA INCREASED 4 0.0002
710 CELLULITIS 12 0.0002
711 PSYCHOTIC DISORDER 7 0.0002
712 MUSCLE ATROPHY 3 0.0002
713 CARDIAC FAILURE CONGESTIVE 19 0.0002
714 ANURIA 2 0.0002
715 CARDIAC MURMUR 2 0.0002
716 ABDOMINAL DISTENSION 24 0.0002
717 PRODUCT DISPENSING ERROR 5 0.0002
718 SUICIDAL IDEATION 21 0.0002
719 WEIGHT INCREASED 51 0.0002
720 HYPOXIA 8 0.0002
721 HYPERSENSITIVITY 42 0.0002
722 WEIGHT DECREASED 63 0.0002
723 LUNG DISORDER 11 0.0002
724 THIRST 4 0.0002
725 RASH PAPULAR 5 0.0002
726 PRODUCT TASTE ABNORMAL 3 0.0002
727 LEUKOCYTOSIS 4 0.0002
728 OSTEOMYELITIS 4 0.0002
729 HYPOTHYROIDISM 7 0.0002
730 SHOCK 5 0.0002
731 NIGHT SWEATS 7 0.0002
732 IRRITABILITY 13 0.0002
733 APHONIA 3 0.0002
734 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 5 0.0002
735 BACTERIAL INFECTION 4 0.0002
736 INSOMNIA 57 0.0002
737 CHOLELITHIASIS 7 0.0002
738 SKIN REACTION 3 0.0002
739 DYSPNOEA EXERTIONAL 8 0.0002
740 STAPHYLOCOCCAL INFECTION 7 0.0002
741 LYMPHOPENIA 3 0.0002
742 BRONCHOSPASM 3 0.0002
743 MUSCULOSKELETAL DISORDER 4 0.0002
744 SKIN DISORDER 7 0.0002
745 CONVULSION 12 0.0002
746 PARAESTHESIA 33 0.0002
747 RECTAL HAEMORRHAGE 9 0.0002
748 INCREASED APPETITE 4 0.0002
749 PARAESTHESIA ORAL 3 0.0002
750 AFFECT LABILITY 2 0.0002
751 ANGER 7 0.0002
752 HYPOKINESIA 3 0.0002
753 MYALGIA 35 0.0002
754 DISTURBANCE IN ATTENTION 11 0.0002
755 DELIRIUM 7 0.0002
756 COLON CANCER 3 0.0002
757 PNEUMONIA 65 0.0002
758 THERAPY NON-RESPONDER 9 0.0002
759 DRUG DOSE OMISSION 33 0.0002
760 APHASIA 6 0.0002
761 EPILEPSY 6 0.0002
762 BODY TEMPERATURE INCREASED 4 0.0002
763 ELECTROCARDIOGRAM QT PROLONGED 7 0.0002
764 BASAL CELL CARCINOMA 3 0.0002
765 URTICARIA 32 0.0002
766 RESPIRATORY TRACT CONGESTION 3 0.0002
767 HOSPITALISATION 29 0.0002
768 ABSCESS 3 0.0002
769 BODY HEIGHT DECREASED 2 0.0002
770 FEAR 5 0.0002
771 DEEP VEIN THROMBOSIS 12 0.0002
772 RASH PRURITIC 10 0.0002
773 DIARRHOEA 119 0.0002
774 CHEST PAIN 34 0.0002
775 HAEMORRHAGE 19 0.0002
776 CYTOMEGALOVIRUS INFECTION 3 0.0002
777 URINARY RETENTION 6 0.0002
778 NAUSEA 142 0.0002
779 WOUND 5 0.0002
780 ADVERSE DRUG REACTION 16 0.0002
781 BLOOD CALCIUM DECREASED 2 0.0002
782 CANDIDA INFECTION 3 0.0002
783 CHROMATURIA 4 0.0002
784 HEMIPARESIS 3 0.0002
785 MULTIPLE ORGAN DYSFUNCTION SYNDROME 5 0.0002
786 CARDIAC FAILURE 14 0.0002
787 CONDITION AGGRAVATED 53 0.0002
788 EXTRA DOSE ADMINISTERED 7 0.0002
789 LOCAL SWELLING 3 0.0002
790 URINARY TRACT INFECTION 29 0.0002
791 LYMPHOCYTE COUNT DECREASED 3 0.0002
792 CARDIAC ARREST 14 0.0002
793 URINARY INCONTINENCE 5 0.0002
794 ARTHRALGIA 70 0.0002
795 PRODUCT PRESCRIBING ERROR 4 0.0002
796 GOUT 3 0.0002
797 BLOOD POTASSIUM DECREASED 5 0.0002
798 PRESYNCOPE 4 0.0002
799 VOMITING 77 0.0002
800 EMOTIONAL DISORDER 5 0.0002
801 OROPHARYNGEAL PAIN 15 0.0002
802 GASTROOESOPHAGEAL REFLUX DISEASE 13 0.0002
803 AGEUSIA 4 0.0002
804 INTESTINAL OBSTRUCTION 6 0.0002
805 BLOOD SODIUM DECREASED 3 0.0002
806 FLATULENCE 9 0.0002
807 MUSCULAR WEAKNESS 18 0.0002
808 BRAIN OEDEMA 2 0.0002
809 FATIGUE 123 0.0002
810 PULMONARY OEDEMA 7 0.0002
811 BACK PAIN 36 0.0002
812 EAR PAIN 3 0.0002
813 BLOOD PRESSURE SYSTOLIC INCREASED 3 0.0002
814 HAEMORRHOIDS 3 0.0002
815 SWELLING FACE 10 0.0002
816 MUSCULOSKELETAL PAIN 8 0.0002
817 EYE DISORDER 5 0.0002
818 ACTIVITIES OF DAILY LIVING IMPAIRED 3 0.0002
819 RESPIRATORY FAILURE 11 0.0002
820 FUNGAL INFECTION 5 0.0001
821 PREGNANCY 3 0.0001
822 SOMNOLENCE 30 0.0001
823 OVERDOSE 32 0.0001
824 OEDEMA PERIPHERAL 18 0.0001
825 CENTRAL NERVOUS SYSTEM LESION 2 0.0001
826 CHILLS 17 0.0001
827 MENTAL STATUS CHANGES 4 0.0001
828 HAEMOPTYSIS 4 0.0001
829 NECK PAIN 8 0.0001
830 EATING DISORDER 3 0.0001
831 SYSTEMIC LUPUS ERYTHEMATOSUS 5 0.0001
832 LIVER FUNCTION TEST INCREASED 3 0.0001
833 POOR QUALITY SLEEP 3 0.0001
834 HERPES ZOSTER 8 0.0001
835 LETHARGY 8 0.0001
836 MYELOSUPPRESSION 5 0.0001
837 FLUID RETENTION 7 0.0001
838 PANIC ATTACK 5 0.0001
839 MALAISE 60 0.0001
840 DYSPHONIA 8 0.0001
841 ACCIDENTAL OVERDOSE 5 0.0001
842 DRY MOUTH 11 0.0001
843 BRONCHITIS 10 0.0001
844 OFF LABEL USE 118 0.0001
845 DIZZINESS 67 0.0001
846 ATRIAL FIBRILLATION 13 0.0001
847 PRURITUS 51 0.0001
848 DEPRESSED MOOD 7 0.0001
849 SUICIDE ATTEMPT 8 0.0001
850 COLITIS 5 0.0001
851 INJECTION SITE REACTION 9 0.0001
852 DRUG EFFECT DECREASED 7 0.0001
853 SYNCOPE 13 0.0001
854 PERICARDIAL EFFUSION 3 0.0001
855 HYPOTENSION 26 0.0001
856 HEADACHE 81 0.0001
857 PAIN IN EXTREMITY 38 0.0001
858 NO ADVERSE EVENT 23 0.0001
859 HEAD INJURY 4 0.0001
860 BLOOD LACTATE DEHYDROGENASE INCREASED 2 0.0001
861 CYSTITIS 4 0.0001
862 HEPATIC CANCER 3 0.0001
863 BLINDNESS 5 0.0001
864 PRODUCT DOSE OMISSION 8 0.0001
865 PRODUCT SUBSTITUTION ISSUE 7 0.0001
866 DRUG INEFFECTIVE 160 0.0001
867 DYSGEUSIA 9 0.0001
868 PNEUMONIA ASPIRATION 3 0.0001
869 HALLUCINATION 9 0.0001
870 UNEVALUABLE EVENT 9 0.0001
871 GLYCOSYLATED HAEMOGLOBIN INCREASED 3 0.0001
872 SKIN EXFOLIATION 10 0.0001
873 CARDIOVASCULAR DISORDER 3 0.0001
874 HYPOPHAGIA 3 0.0001
875 PRODUCT USE IN UNAPPROVED INDICATION 29 0.0001
876 HYPERHIDROSIS 15 0.0001
877 DECREASED APPETITE 27 0.0001
878 HAEMATOMA 3 0.0001
879 BALANCE DISORDER 10 0.0001
880 STOMATITIS 7 0.0001
881 RESPIRATORY TRACT INFECTION 3 0.0001
882 TREMOR 19 0.0001
883 GASTRITIS 3 0.0001
884 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 8 0.0001
885 THERAPEUTIC RESPONSE UNEXPECTED 5 0.0001
886 PRODUCT QUALITY ISSUE 15 0.0001
887 PALLOR 3 0.0001
888 GASTROINTESTINAL HAEMORRHAGE 9 0.0001
889 HAEMOGLOBIN DECREASED 11 0.0001
890 EYE PAIN 6 0.0001
891 TARDIVE DYSKINESIA 3 0.0001
892 NEOPLASM MALIGNANT 7 0.0001
893 PRODUCTIVE COUGH 5 0.0001
894 RASH ERYTHEMATOUS 5 0.0001
895 BONE PAIN 6 0.0001
896 MEMORY IMPAIRMENT 14 0.0001
897 LOSS OF CONSCIOUSNESS 13 0.0001
898 CATARACT 6 0.0001
899 RESPIRATORY DISORDER 3 0.0001
900 INJURY 7 0.0001
901 THROMBOSIS 8 0.0001
902 FALL 33 0.0001
903 DYSPNOEA 56 0.0001
904 THERAPY CESSATION 5 0.0001
905 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 5 0.0001
906 ECZEMA 5 0.0001
907 BLOOD GLUCOSE INCREASED 18 0.0001
908 MOOD SWINGS 3 0.0001
909 METABOLIC ACIDOSIS 3 0.0001
910 EPISTAXIS 7 0.0001
911 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
912 VAGINAL HAEMORRHAGE 4 0.0001
913 ALOPECIA 18 0.0001
914 VIRAL INFECTION 3 0.0001
915 LIP SWELLING 3 0.0001
916 MEDICATION ERROR 5 0.0001
917 INFECTION 13 0.0001
918 ARTHRITIS 7 0.0001
919 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 3 0.0001
920 VISUAL IMPAIRMENT 11 0.0001
921 ASTHMA 10 0.0001
922 MUSCLE SPASMS 16 0.0001
923 SKIN DISCOLOURATION 4 0.0001
924 RASH MACULAR 3 0.0001
925 SWELLING 8 0.0001
926 PRODUCT USE ISSUE 16 0.0001
927 ABDOMINAL DISCOMFORT 14 0.0001
928 CEREBROVASCULAR ACCIDENT 14 0.0001
929 ABDOMINAL PAIN UPPER 17 0.0001
930 FEELING HOT 5 0.0001
931 AGGRESSION 4 0.0001
932 COVID-19 14 0.0001
933 SEIZURE 9 0.0001
934 DEPRESSED LEVEL OF CONSCIOUSNESS 3 0.0001
935 ABNORMAL BEHAVIOUR 3 0.0001
936 FEBRILE NEUTROPENIA 5 0.0001
937 FEELING ABNORMAL 18 0.0001
938 INCORRECT DOSE ADMINISTERED 17 0.0001
939 INFLUENZA 8 0.0001
940 BLISTER 4 0.0001
941 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 5 0.0001
942 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 14 0.0001
943 PRODUCT STORAGE ERROR 6 0.0001
944 PALPITATIONS 8 0.0001
945 SURGERY 4 0.0001
946 THROAT IRRITATION 3 0.0001
947 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 12 0.0001
948 HOT FLUSH 5 0.0001
949 PLATELET COUNT DECREASED 7 0.0001
950 DISCOMFORT 4 0.0001
951 NASOPHARYNGITIS 12 0.0001
952 PERIPHERAL SWELLING 10 0.0001
953 CONSTIPATION 14 0.0001
954 CARDIAC DISORDER 6 0.0001
955 ARRHYTHMIA 3 0.0001
956 COMA 3 0.0001
957 RENAL CANCER 3 0.0001
958 DYSPEPSIA 6 0.0001
959 COUGH 17 0.0001
960 INFUSION RELATED REACTION 4 0.0001
961 BLOOD PRESSURE DECREASED 4 0.0001
962 CHEST DISCOMFORT 6 0.0001
963 VISION BLURRED 8 0.0001
964 BRADYCARDIA 3 0.0001
965 WHITE BLOOD CELL COUNT DECREASED 6 0.0001
966 C-REACTIVE PROTEIN INCREASED 2 0.0001
967 UNDERDOSE 4 0.0001
968 INJECTION SITE SWELLING 4 0.0001
969 DISEASE PROGRESSION 6 0.0001
970 ILL-DEFINED DISORDER 3 0.0000
971 INFLUENZA LIKE ILLNESS 4 0.0000
972 INTENTIONAL OVERDOSE 3 0.0000
973 BLOOD PRESSURE INCREASED 7 0.0000
974 INTENTIONAL PRODUCT MISUSE 4 0.0000
975 INTENTIONAL PRODUCT USE ISSUE 4 0.0000
976 INJECTION SITE PRURITUS 3 0.0000
977 BLOOD GLUCOSE DECREASED 2 0.0000
978 FLUSHING 4 0.0000
979 SINUSITIS 4 0.0000
980 DRUG ABUSE 3 0.0000
981 MUSCULOSKELETAL STIFFNESS 3 0.0000
982 JOINT SWELLING 4 0.0000
983 CONTUSION 3 0.0000
984 PRODUCT DOSE OMISSION ISSUE 8 0.0000
985 RHEUMATOID ARTHRITIS 3 0.0000
986 ACNE 2 0.0000
987 INJECTION SITE PAIN 6 0.0000